Dr. Nazha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1365 Clifton Rd NE Bldg C
Winship Cancer Institute
Atlanta, GA 30322Phone+1 404-778-1900- Is this information wrong?
Education & Training
- Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2020
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2017
- Columbia UniversityMPH, Health Policy and Management, 2014
- American University of Beirut Faculty of MedicineClass of 2013, MD
- McGill UniversityBS, Biology, Great Distinction, 2008
Certifications & Licensure
- GA State Medical License 2020 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma Start of enrollment: 2021 May 20
Roles: Principal Investigator, Contact
- Cabozantinib in Combination With Atezolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer Start of enrollment: 2024 Apr 01
Roles: Contact, Principal Investigator
- Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology Start of enrollment: 2023 Sep 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches.Chukkalore, D., MacDougall, K., Master, V., Bilen, M., Nazha, B.> ;The Oncologist. 2024 Feb 21
- Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.Nicaise, E., Schmeusser, B., Ali, A., Midenberg, E., Palacios, A., Hartsoe, B., Kearns, E., Ambadi, S., Patil, D., Joshi, S., Narayan, V., Psutka, S., Nazha, B., Brown...> ;Clinical Genitourinary Cancer. 2024 Feb 16
- Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.Sanda, G., Shabto, J., Goyal, S., Liu, Y., Martini, D., Nazha, B., Brown, J., Yantorni, L., Anne Russler, G., Caulfield, S., Joshi, S., Narayan, V., Kissick, H., Ogan,...> ;The Oncologist. 2023 Dec 11
- Join now to see all
Press Mentions
- The Case for Immunotherapy Trials That Reflect the Real World of Metastatic MelanomaSeptember 13th, 2019
Other Languages
- French, Arabic
Hospital Affiliations
- Emory University Hospital MidtownAtlanta, Georgia
- Grady Health SystemAtlanta, Georgia
External Links
- Winship Cancer Institute profilehttps://winshipcancer.emory.edu/bios/faculty/nazha-bassel.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: